231 related articles for article (PubMed ID: 16647416)
1. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists.
Chipps BE; Spahn JD; Sorkness CA; Baitinger L; Sutton LB; Emmett AH; Dorinsky PM
J Pediatr; 2006 Apr; 148(4):517-21. PubMed ID: 16647416
[TBL] [Abstract][Full Text] [Related]
2. Asthma variability in patients previously treated with beta2-agonists alone.
Calhoun WJ; Sutton LB; Emmett A; Dorinsky PM
J Allergy Clin Immunol; 2003 Dec; 112(6):1088-94. PubMed ID: 14657863
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
4. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
5. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
[TBL] [Abstract][Full Text] [Related]
6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
7. FEF75 in asthma management.
Luigi DB; Emanuel DT; Federica DB; Fabrizio DT
Eur Ann Allergy Clin Immunol; 2007 Dec; 39(10):333-6. PubMed ID: 18386434
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
Morris NV; Abramson MJ; Strasser RP
Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
[TBL] [Abstract][Full Text] [Related]
10. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Bleecker ER; Yancey SW; Baitinger LA; Edwards LD; Klotsman M; Anderson WH; Dorinsky PM
J Allergy Clin Immunol; 2006 Oct; 118(4):809-16. PubMed ID: 17030231
[TBL] [Abstract][Full Text] [Related]
11. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
12. The influence of variation in type and pattern of symptoms on assessment in pediatric asthma.
Fuhlbrigge AL; Guilbert T; Spahn J; Peden D; Davis K
Pediatrics; 2006 Aug; 118(2):619-25. PubMed ID: 16882815
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Acute Asthma Care Among Inner-city Adults.
Coyle YM; Aragaki CC; Hynan LS; Gruchalla RS; Khan DA
Arch Intern Med; 2003 Jul; 163(13):1591-6. PubMed ID: 12860583
[TBL] [Abstract][Full Text] [Related]
14. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
15. Value of the bronchodilator response in assessing controller naïve asthmatic children.
Galant SP; Morphew T; Amaro S; Liao O
J Pediatr; 2007 Nov; 151(5):457-62, 462.e1. PubMed ID: 17961685
[TBL] [Abstract][Full Text] [Related]
16. When should a reversibility test be performed on patients with early stages of asthma and normal spirometry?
Sposato B; Mariotta S; Ricci A
J Asthma; 2008 Aug; 45(6):479-83. PubMed ID: 18612900
[TBL] [Abstract][Full Text] [Related]
17. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
18. Disability and breathlessness in asthmatic patients--a scoring method by repetitive inspiratory effort.
Loh LC; Puah SH; Ho CV; Chow CY; Chua CY; Jayaram J; Kavetha C; Wong SJ
J Asthma; 2005 Dec; 42(10):853-8. PubMed ID: 16393724
[TBL] [Abstract][Full Text] [Related]
19. Current asthma guidelines may not identify young children who have experienced significant morbidity.
Galant SP; Morphew T; Amaro S; Liao O
Pediatrics; 2006 Apr; 117(4):1038-45. PubMed ID: 16585297
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of severity of bronchial asthma through an exercise bronchial challenge.
Lazo-Velásquez JC; Lozada AR; Cruz HM
Pediatr Pulmonol; 2005 Nov; 40(5):457-63. PubMed ID: 16175592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
